Innate Pharma consolidates shares at 1.70 euros following corporate action

Innate Pharma announces the consolidation of its shares at 1.70 euros following a corporate action.

Published 5j1 sourceupdated 5j

≈ 18sSpeed

The fact

The Marseille-based biotech firm, focused on oncology, adjusts its capital to strengthen its structure.

This operation could attract new institutional investors.

Click the link to read an article on the topic:

Explore this topic

Auto-synthesis from 1 media source · identified on August 17, 2026